Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Roche Diagnostics cobas Liat SARS-CoV-2 Assay
Nucleic acid test for use on cobas Liat system is the first real-time RT-PCR test authorized for use in screening and testing asymptomatic/symptomatic individuals for SARS-CoV-2 at the point of care
Supplier: Roche Diagnostics 09408592190
Alert:
Order eligibility is based upon executed contractual agreement.
Description
- Screen asymptomatic individuals to help prevent the silent spread of SARS-CoV-2
- Provide answers patients need in 20 min. enabling quick actions to manage patient care
- Offers broad strain coverage of SARS-CoV-2 variants
Specifications
EUA | |
SARS-CoV-2 Control Kit used to verify each new lot of SARS-CoV-2 assay | |
Yes | |
ORF 1a/b & N gene SARS-CoV-2 | |
Assay Tube | |
SARS-CoV-2: Symptomatic individuals: 96.1% Positive Agreement, 96.8% Negative Agreement; Asymptomatic individuals 100% Positive Agreement, 98.9% Negative Agreement* *compared to an FDA-cleared EUA, Cobas™ SARS-CoV-2 Test on Cobas™ 6800/8800 systems | |
Single-use | |
Cobas™ Liat system analyzer | |
RT-PCR | |
Cold chain | |
Dual-target ORF 1a/b & N gene SARS-CoV-2 |
2°C to 8°C | |
87635 | |
Waived (EUA) | |
Yes | |
Nasopharyngeal swab, Mid turbinate swab, Nasal swab | |
Assay Kit | |
RT-PCR | |
Plastic | |
20 Tests/Kit | |
Non-sterile | |
20 min. |
Safety and Handling
ShelfLife : 12 Months
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Product Content Correction